UY24886A1 - Tiazolidindiona - Google Patents

Tiazolidindiona

Info

Publication number
UY24886A1
UY24886A1 UY24886A UY24886A UY24886A1 UY 24886 A1 UY24886 A1 UY 24886A1 UY 24886 A UY24886 A UY 24886A UY 24886 A UY24886 A UY 24886A UY 24886 A1 UY24886 A1 UY 24886A1
Authority
UY
Uruguay
Prior art keywords
thiazolidinedione
pyridyl
ethoxy
amino
methyl
Prior art date
Application number
UY24886A
Other languages
English (en)
Inventor
Michael Urquhart
John Kirby Quick
Colin Ripley Pool
Stephen Moore
Norman John Lewis
Robert Gordon Glies
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY24886(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9703310.4A external-priority patent/GB9703310D0/en
Priority claimed from GBGB9703338.5A external-priority patent/GB9703338D0/en
Priority claimed from GBGB9703334.4A external-priority patent/GB9703334D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of UY24886A1 publication Critical patent/UY24886A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Procedimiento para preparar derivados de 1,3 tiazoles o 1,3 oxazoles que comprende reducir un precursor de los mismos con hidruro complejo. La invención se refiere a un compuesto intermedio de fórmula (III) o una de sus formas tautómeras, o de sus sales, o de sus solvatos, donde J es O o S; T representa un grupo arilo sustituído o no, para la preparación de un compuesto de fórmula (I) o una de sus sales farmacéuticamente aceptables, donde J es O ó S; T es arilo sustituído y T1 es O ó S. Ejemplo: 5-(4-(2-(N-metil-N-(2-piridil)amino)etoxi)bencil)-2,4-tiazolidindiona (IA) por reducción de 5-(4-(2-(N-metil-N-(2-piridil)amino)etoxi)bencilidin)2,4-tiazolidindiona(IIB)
UY24886A 1997-02-18 1998-02-11 Tiazolidindiona UY24886A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9703310.4A GB9703310D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703338.5A GB9703338D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703334.4A GB9703334D0 (en) 1997-02-18 1997-02-18 Novel compounds

Publications (1)

Publication Number Publication Date
UY24886A1 true UY24886A1 (es) 2001-08-27

Family

ID=27268725

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24886A UY24886A1 (es) 1997-02-18 1998-02-11 Tiazolidindiona

Country Status (29)

Country Link
EP (2) EP0970063A1 (es)
JP (2) JP2001514619A (es)
KR (1) KR20000071138A (es)
CN (1) CN1252065A (es)
AP (1) AP1359A (es)
AR (1) AR011447A1 (es)
AU (1) AU6622398A (es)
BG (1) BG64311B1 (es)
BR (1) BR9807395A (es)
CA (1) CA2281695C (es)
CZ (1) CZ296272B6 (es)
DZ (1) DZ2430A1 (es)
EA (1) EA199900754A1 (es)
HU (1) HUP0001459A3 (es)
ID (1) ID22222A (es)
IL (1) IL131392A (es)
IN (1) IN188379B (es)
MA (1) MA24475A1 (es)
MY (1) MY129475A (es)
NO (2) NO313290B1 (es)
NZ (1) NZ337179A (es)
OA (1) OA11148A (es)
PE (1) PE71899A1 (es)
PL (1) PL195482B1 (es)
SK (2) SK285979B6 (es)
TR (1) TR199902019T2 (es)
TW (1) TWI222446B (es)
UY (1) UY24886A1 (es)
WO (1) WO1998037073A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
GB9723295D0 (en) 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
ES2203453T3 (es) * 1999-04-23 2004-04-16 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
FR2820741A1 (fr) * 2001-02-14 2002-08-16 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
OA12963A (en) 2002-11-22 2006-10-13 Smithkline Beecham Corp Novel chemical compounds.
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
CA2566352A1 (en) * 2004-05-12 2005-11-17 Medichem S.A. Process for the preparation of rosiglitazone
CZ297266B6 (cs) * 2004-09-10 2006-10-11 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
JPH0377875A (ja) * 1989-08-18 1991-04-03 Kaken Pharmaceut Co Ltd チアゾリジン‐２，４‐ジオン誘導体およびその製造法
EP0454501B1 (en) * 1990-04-27 2001-09-05 Sankyo Company Limited Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
US5585495A (en) * 1991-12-20 1996-12-17 The Upjohn Company Reduction method for substituted 5-methylene-thiazolidinediones
JPH08157473A (ja) * 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
JPH08217717A (ja) * 1995-02-10 1996-08-27 Sumitomo Chem Co Ltd 環状ケトン系化合物、その製造法およびそれを有効成分とするゴキブリ誘引剤
NZ308228A (en) * 1995-05-31 1999-11-29 Sumitomo Pharma Substituted 1,8-naphthyridine derivatives

Also Published As

Publication number Publication date
ID22222A (id) 1999-09-16
JP2009149616A (ja) 2009-07-09
NO20023937D0 (no) 2002-08-19
IN188379B (es) 2002-09-14
IL131392A (en) 2005-07-25
MA24475A1 (fr) 1998-10-01
JP2001514619A (ja) 2001-09-11
SK112099A3 (en) 2000-05-16
NO313290B1 (no) 2002-09-09
CZ292499A3 (cs) 2000-02-16
CA2281695A1 (en) 1998-08-27
PL335163A1 (en) 2000-04-10
BG103735A (en) 2000-06-30
OA11148A (en) 2003-04-16
AP1359A (en) 2004-12-02
NZ337179A (en) 2001-07-27
AP9901626A0 (en) 1999-09-30
BR9807395A (pt) 2000-03-14
CZ296272B6 (cs) 2006-02-15
NO993949D0 (no) 1999-08-17
SK287512B6 (sk) 2010-12-07
HUP0001459A3 (en) 2002-11-28
WO1998037073A1 (en) 1998-08-27
EP1770092A1 (en) 2007-04-04
AU6622398A (en) 1998-09-09
NO20023937L (no) 1999-09-07
EP0970063A1 (en) 2000-01-12
IL131392A0 (en) 2001-01-28
PE71899A1 (es) 1999-09-15
DZ2430A1 (fr) 2003-01-11
AR011447A1 (es) 2000-08-16
CN1252065A (zh) 2000-05-03
TWI222446B (en) 2004-10-21
KR20000071138A (ko) 2000-11-25
TR199902019T2 (xx) 1999-12-21
PL195482B1 (pl) 2007-09-28
NO993949L (no) 1999-09-07
BG64311B1 (bg) 2004-09-30
HUP0001459A2 (hu) 2000-10-28
SK285979B6 (sk) 2007-12-06
CA2281695C (en) 2006-12-12
MY129475A (en) 2007-04-30
EA199900754A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
CY1107238T1 (el) Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
BR0108870A (pt) Sais cloridrato de 5-[4-[2-(n-metil-n-(2-piridil) amino) etoxi] benzil] tiazolidino-2,4-diona
UY24886A1 (es) Tiazolidindiona
AU2001284658A1 (en) Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
ATE212991T1 (de) Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften
CO4950567A1 (es) Inhibidores de proteasas dores de proteasas.
UY25227A1 (es) Procedimiento para preparar 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-2,4-tiazolidindiona
HUP0402038A2 (hu) 2-Amino-4-heteroaril-etil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EA200200470A1 (ru) Новые производные тиазолидиндиона в качестве противодиабетических средств
HRP20010630B1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
EA200300345A1 (ru) Гидрохлоридная соль 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона
HUP0304096A2 (hu) Eljárás pioglitazon hidrogénklorid előállítására és intermedierjei
MX9305918A (es) Derivados de n-(2-amino-2-oxoetil)butanodiamida inhibidores de la renina procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
ATE269862T1 (de) Substituierte thiazolidinedione und oxazolidinedione mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften
DK1315724T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetikum
EA200300005A1 (ru) Соль тиазолидиндиона для лечения сахарного диабета
WO2002028857A8 (en) Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
EA200300231A1 (ru) Тартратные соли производного тиазолидиндиона
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
ES2154551B1 (es) Nuevos derivados de tetrazol como agentes antidiabeticos.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20131007